Evolutions in the Management of Duchenne Muscular Dystrophy (DMD): Treatment Implications for the Present and Future

Target Audience
This educational activity is intended for healthcare professionals involved in the management of patients with Duchenne Muscular Dystrophy (DMD), including neurologists, neuromuscular specialists, and other members of the healthcare team who care for patients with DMD.

Program Overview
Duchenne muscular dystrophy (DMD) impacts 1 in every 3,500 male births globally, and its progression is both relentless and fatal. However, the rapid advancement in DMD therapies brings hope and substantial progress for those battling this devastating condition. Selecting the optimal treatment regimen for each patient at the right time demands meticulous evaluation. This activity empowers clinicians managing DMD patients to navigate and comprehend the evolving landscape of clinical trial data across diverse treatment modalities, ensuring the best possible care.

Learning Objectives
Upon completion of this activity, participants should be better able to:

Describe the role of dystrophin disruption and restoration in the progression and management of DMD
Assess the latest clinical trial results across various treatment modalities for DMD
Examine emerging approaches to DMD management that seek to align patient selection, treatment choice, and optimal initiation of therapy